These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6460184

  • 21. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG, Oliveira MP, Da-Cruz AM, De Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D.
    Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
    [Abstract] [Full Text] [Related]

  • 22. The cutaneous lesion in American leishmaniasis: leukocyte subsets, cellular interaction and cytokine production.
    Tapia FJ, Caceres-Dittmar G, Sanchez MA, Fernandez AE, Convit J.
    Biol Res; 1993 Nov; 26(1-2):239-47. PubMed ID: 7545501
    [Abstract] [Full Text] [Related]

  • 23. Modulation of the host response in human schistosomiasis. IV. Parasite antigen induces release of histamine that inhibits lymphocyte responsiveness in vitro.
    Hofstetter M, Fasano MB, Ottesen EA.
    J Immunol; 1983 Mar; 130(3):1376-80. PubMed ID: 6185579
    [Abstract] [Full Text] [Related]

  • 24. In vitro generation of adherent mononuclear suppressor cells to Toxoplasma antigen.
    Luft BJ, Pedrotti PW, Remington JS.
    Immunology; 1988 Apr; 63(4):643-8. PubMed ID: 2966766
    [Abstract] [Full Text] [Related]

  • 25. Characterization of the cellular immune response in American cutaneous leishmaniasis.
    Castes M, Agnelli A, Verde O, Rondón AJ.
    Clin Immunol Immunopathol; 1983 May; 27(2):176-86. PubMed ID: 6409480
    [Abstract] [Full Text] [Related]

  • 26. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
    Scott P, Natovitz P, Sher A.
    J Immunol; 1986 Aug 01; 137(3):1017-21. PubMed ID: 3487581
    [Abstract] [Full Text] [Related]

  • 27. Serodiagnosis of leishmaniasis.
    Kar K.
    Crit Rev Microbiol; 1995 Aug 01; 21(2):123-52. PubMed ID: 7639932
    [Abstract] [Full Text] [Related]

  • 28. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
    Koster FT, Williams JC, Goodwin JS.
    J Immunol; 1985 Aug 01; 135(2):1067-72. PubMed ID: 2409135
    [Abstract] [Full Text] [Related]

  • 29. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
    Saha B, Das G, Vohra H, Ganguly NK, Mishra GC.
    Eur J Immunol; 1995 Sep 01; 25(9):2492-8. PubMed ID: 7589116
    [Abstract] [Full Text] [Related]

  • 30. Recognition of protozoan parasites by murine T lymphocytes. II. Role of the H-2 gene complex in interactions between antigen-presenting macrophages and Leishmania-immune T lymphocytes.
    Louis JA, Moedder E, MacDonald HR, Engers HD.
    J Immunol; 1981 May 01; 126(5):1661-6. PubMed ID: 6452473
    [Abstract] [Full Text] [Related]

  • 31. Immunosuppression in Kenyan visceral leishmaniasis.
    Ho M, Koech DK, Iha DW, Bryceson AD.
    Clin Exp Immunol; 1983 Feb 01; 51(2):207-14. PubMed ID: 6839538
    [Abstract] [Full Text] [Related]

  • 32. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH, Rich RR, Smith TK.
    J Clin Invest; 1972 Nov 01; 51(11):2948-58. PubMed ID: 5080419
    [Abstract] [Full Text] [Related]

  • 33. Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.
    Valli LC, Passos VM, Dietze R, Callahan HL, Berman JD, Grogl M.
    J Parasitol; 1999 Dec 01; 85(6):1076-83. PubMed ID: 10647040
    [Abstract] [Full Text] [Related]

  • 34. Blast transformation in different stages of cutaneous leishmaniasis.
    Witztum E, Spira DT, Zuckerman A.
    Isr J Med Sci; 1978 Feb 01; 14(2):244-7. PubMed ID: 649353
    [Abstract] [Full Text] [Related]

  • 35. Parasitic disease as a cause of immunosuppression.
    Nussenzweig RS.
    N Engl J Med; 1982 Feb 18; 306(7):423-4. PubMed ID: 6460186
    [No Abstract] [Full Text] [Related]

  • 36. Parasite-driven in vitro human lymphocyte cytotoxicity against autologous infected macrophages from mucosal leishmaniasis.
    Brodskyn CI, Barral A, Boaventura V, Carvalho E, Barral-Netto M.
    J Immunol; 1997 Nov 01; 159(9):4467-73. PubMed ID: 9379046
    [Abstract] [Full Text] [Related]

  • 37. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1982 Apr 01; 128(4):1917-22. PubMed ID: 6120976
    [Abstract] [Full Text] [Related]

  • 38. Comparative study of American cutaneous leishmaniasis and diffuse cutaneous leishmaniasis in two strains of inbred mice.
    Pérez H, Arredondo B, González M.
    Infect Immun; 1978 Nov 01; 22(2):301-7. PubMed ID: 730354
    [Abstract] [Full Text] [Related]

  • 39. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells.
    Peters N, Sacks D.
    Immunol Rev; 2006 Oct 01; 213():159-79. PubMed ID: 16972903
    [Abstract] [Full Text] [Related]

  • 40. Reversible defect in antigen-induced lymphokine and gamma-interferon generation in cutaneous leishmaniasis.
    Murray HW, Rubin BY, Carriero S, Acosta AM.
    J Immunol; 1984 Oct 01; 133(4):2250-4. PubMed ID: 6432909
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.